+

WO2003011217A3 - Extraits de grifola et leurs procedes d'utilisation - Google Patents

Extraits de grifola et leurs procedes d'utilisation Download PDF

Info

Publication number
WO2003011217A3
WO2003011217A3 PCT/US2002/023883 US0223883W WO03011217A3 WO 2003011217 A3 WO2003011217 A3 WO 2003011217A3 US 0223883 W US0223883 W US 0223883W WO 03011217 A3 WO03011217 A3 WO 03011217A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracts
methods
grifola
alopecia
reductase
Prior art date
Application number
PCT/US2002/023883
Other languages
English (en)
Other versions
WO2003011217A9 (fr
WO2003011217A2 (fr
Inventor
Robert J Barry
Geetha Govindan
Andrew Miller
Original Assignee
Tanical Therapeutics Inc
Robert J Barry
Geetha Govindan
Andrew Miller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanical Therapeutics Inc, Robert J Barry, Geetha Govindan, Andrew Miller filed Critical Tanical Therapeutics Inc
Priority to AU2002322702A priority Critical patent/AU2002322702A1/en
Publication of WO2003011217A2 publication Critical patent/WO2003011217A2/fr
Publication of WO2003011217A3 publication Critical patent/WO2003011217A3/fr
Publication of WO2003011217A9 publication Critical patent/WO2003011217A9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention porte sur des extraits phytochimiques de la Grifola frondosa et en particulier sur des extraits aqueux et éthyliques. Lesdits extraits présentent in vitro une activité inhibitrice de la 5-α-réductase et des androgènes et s'avèrent de ce fait utiles pour traiter l'hyperplasie bénigne de la prostate et l'alopécie.
PCT/US2002/023883 2001-07-27 2002-07-29 Extraits de grifola et leurs procedes d'utilisation WO2003011217A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002322702A AU2002322702A1 (en) 2001-07-27 2002-07-29 Grifola extracts and methods of use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30831901P 2001-07-27 2001-07-27
US60/308,319 2001-07-27

Publications (3)

Publication Number Publication Date
WO2003011217A2 WO2003011217A2 (fr) 2003-02-13
WO2003011217A3 true WO2003011217A3 (fr) 2003-05-08
WO2003011217A9 WO2003011217A9 (fr) 2003-11-20

Family

ID=23193498

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/023883 WO2003011217A2 (fr) 2001-07-27 2002-07-29 Extraits de grifola et leurs procedes d'utilisation

Country Status (2)

Country Link
AU (1) AU2002322702A1 (fr)
WO (1) WO2003011217A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7597910B2 (en) * 2005-08-20 2009-10-06 Slgm Medical Research Institute Compositions and methods for treating prostate disorders
JP2009191009A (ja) * 2008-02-14 2009-08-27 Yukiguni Maitake Co Ltd 免疫賦活作用および抗腫瘍作用を有するマイタケ由来の低分子物質

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854404A (en) * 1996-03-08 1998-12-29 Yukiguni Maitake Co., Ltd. Antitumor substance extracted from grifola

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854404A (en) * 1996-03-08 1998-12-29 Yukiguni Maitake Co., Ltd. Antitumor substance extracted from grifola

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FULLERTON ET AL.: "Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide)", MOLECULAR UROLOGY, vol. 4, no. 1, 2000, pages 7 - 13, XP002959144 *

Also Published As

Publication number Publication date
WO2003011217A9 (fr) 2003-11-20
WO2003011217A2 (fr) 2003-02-13
AU2002322702A1 (en) 2003-02-17

Similar Documents

Publication Publication Date Title
MXPA03005893A (es) Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina.
IL158115A0 (en) Sapogenin derivatives, their synthesis and use, and methods based upon their use
AU2001268535A1 (en) Devices and methods for repair of valves in the human body
WO2002094002A3 (fr) Bois d'agar de culture
MX248298B (es) Prepinturas y metodos para preparar pinturas a partir de estas prepinturas.
MXPA02008801A (es) Derivados de indol, proceso para la preparacion de los mismos y su uso.
AU5208401A (en) 3-nitrogen-6,7-dioxygen steroids and uses related thereto
MXPA03007827A (es) Metodo y composicion para la coloracion permanente gradual de cabello.
AU4229200A (en) Methods and compositions for treating dermatological disorders with fruit extracts
AU2002247715A1 (en) Rylene derivatives and their use as dyes
CA2392620A1 (fr) Melatonine servant a traiter l'alopecie androgenetique et diffuse
AU2002363372A1 (en) Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
AU2002241508A1 (en) Membrane derived caspase-3, compositions comprising the same and methods of use therefor
AU2002211660A1 (en) Ginseng berry extracts and pharmaceutical compositions therefrom
AU2002215333A1 (en) Compositions for release of radiosensitizers, and methods of making and using the same
AU2002216650A1 (en) Triazine derivatives as lpaat-b inhibitors and uses thereof
WO2003011217A3 (fr) Extraits de grifola et leurs procedes d'utilisation
AU1704601A (en) Use of flavones and/or isoflavones from plant extracts
AU2003223644A1 (en) Isoflavone and triterpene glycosides from soybeans
AU2003261612A1 (en) Derivatives of triptolide having high immunosuppressive effect and high water solubility, and uses thereof
AU2001275778A1 (en) Lemon extract and treatment methods
DE60023303D1 (de) Acetamidocalixarenderivate, ihre herstellung sowie ihre anwendung für die extraktion von strontium
WO2002024179A3 (fr) Procede de reduction de la toxicite de chimiotherapies combinees
TWI315739B (en) Modified yeasts and uses, in particular for the production of steroidal derivatives
HK1049485A1 (en) DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
COP Corrected version of pamphlet

Free format text: PAGES 1/5-5/5, DRAWINGS, REPLACED BY NEW PAGES 1/8-8/8; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTIFICATION OF LOSS OF RIGHTS PERSUANT TO RULE 69(1) EPC (EPO FORM 1205A SENT ON 26.05.04)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载